Patents by Inventor Lludmila Aleksandrovna Berezina

Lludmila Aleksandrovna Berezina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9669061
    Abstract: The invention belongs in the field of medicine and can be used in the treatment of chronic and asymptomatic trichomonas infections of the urogenital tract. The invention is consisted in development of new therapeutic substance of plant origin with minimal side effects for treatment of various forms of trichomonad infection. The new therapeutic substance, of plant origin, is an olive coloured paste. It is composed of a conifer green needle complex (CGNC) and has a coniferous smell and antiprotozoal activity against Trichomonas vaginalis (when tested in an in vitro model). At a concentration of 100 mg/ml CGNC has trichomonadocitic and trichomonadostatic properties. At 300 mg/ml it suppresses the growth of T. vaginalis and at 500 mg/ml it kills this organism.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: June 6, 2017
    Assignees: Viktor Ivanovich Roschin, Vagif Sultanovich Sultanov
    Inventors: Viktor Ivanovich Roschin, Vagif Sultanovich Sultanov, Anatolii Borisovich Zhebrun, Tamara Valentinovna Nikitina, Lidija Borisovna Kuliashova, Lludmila Aleksandrovna Berezina
  • Publication number: 20110189321
    Abstract: The invention belongs in the field of medicine and can be used in the treatment of chronic and asymptomatic trichomonas infections of the urogenital tract. The invention is consisted in development of new therapeutic substance of plant origin with minimal side effects for treatment of various forms of trichomonad infection. The new therapeutic substance, of plant origin, is an olive coloured paste. It is composed of a conifer green needle complex (CGNC) and has a coniferous smell and antiprotozoal activity against Trichomonas vaginalis (when tested in an in vitro model). At a concentration of 100 mg/ml CGNC has trichomonadocitic and trichomonadostatic properties. At 300 mg/ml it suppresses the growth of T. vaginalis and at 500 mg/ml it kills this organism.
    Type: Application
    Filed: May 5, 2009
    Publication date: August 4, 2011
    Applicant: Viktor Ivanovich ROSCHIN
    Inventors: Viktor Ivanovich Roschin, Vagif Sultanovich Sultanov, Anatolii Borisovich Zhebrun, Tamara Valentinovna Nikitina, Lidija Borisovna Kuliashova, Lludmila Aleksandrovna Berezina